UnitedHealth Group Incorporated $UNH Shares Acquired by Precedent Wealth Partners LLC

Precedent Wealth Partners LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 32.7% in the second quarter, Holdings Channel reports. The institutional investor owned 3,145 shares of the healthcare conglomerate’s stock after buying an additional 775 shares during the quarter. Precedent Wealth Partners LLC’s holdings in UnitedHealth Group were worth $981,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Consolidated Investment Group LLC boosted its holdings in UnitedHealth Group by 26.4% in the second quarter. Consolidated Investment Group LLC now owns 16,750 shares of the healthcare conglomerate’s stock worth $5,225,000 after purchasing an additional 3,500 shares during the period. Curran Financial Partners LLC boosted its holdings in UnitedHealth Group by 27.2% in the second quarter. Curran Financial Partners LLC now owns 962 shares of the healthcare conglomerate’s stock worth $300,000 after purchasing an additional 206 shares during the period. Barrett & Company Inc. boosted its holdings in UnitedHealth Group by 28.5% in the second quarter. Barrett & Company Inc. now owns 1,181 shares of the healthcare conglomerate’s stock worth $368,000 after purchasing an additional 262 shares during the period. Montz Harcus Wealth Management LLC boosted its holdings in UnitedHealth Group by 12.2% in the second quarter. Montz Harcus Wealth Management LLC now owns 679 shares of the healthcare conglomerate’s stock worth $212,000 after purchasing an additional 74 shares during the period. Finally, New Century Financial Group LLC boosted its holdings in UnitedHealth Group by 263.0% in the second quarter. New Century Financial Group LLC now owns 4,410 shares of the healthcare conglomerate’s stock worth $1,376,000 after purchasing an additional 3,195 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $360.17 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $326.20 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. The company’s 50-day moving average price is $307.84 and its two-hundred day moving average price is $355.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Oppenheimer reduced their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Truist Financial boosted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. Finally, Barclays lifted their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.